- Workshop presentation
- Open Access
Contrast enhanced magnetic resonance angiography in children: initial experience at 3.0 Tesla
© Khan et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Image Quality
- Pediatric Patient
- Congenital Heart Disease
- Magnetic Resonance Angiography
- Diagnostic Performance
To assess the role of contrast enhanced magnetic resonance angiography (CEMRA) at 3.0T in pediatric patients referred for vascular evaluation, and to compare the technical and diagnostic performance of a clinically similar control group at 1.5T.
Fifty pediatric patients referred for vascular evaluation and without evidence of congenital heart disease, were evaluated with CEMRA. Thirty-five patients received 37 studies at 3.0T (age 0.4 -16.5 years, mean 5.8 ± 4.7 years. Fifteen patients received 16 studies at 1.5T (age 0.1 - 17.5 years, mean 5.8 ± 6.4 years). CEMRA was performed in three phases: arterial, early venous and late venous. Two independent observers analyzed the studies for image quality, artifacts and vessel definition.
CEMRA at 3.0T and 1.5T produces diagnostic quality studies for pre-and post-transplantation vascular assessment in pediatric patients. For optimum image quality and spatial resolution, the use of 3.0T MRA with controlled ventilation is recommended if readily available.
Siemens Research Grant
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.